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associated lymphoproliferative disorders were observed 
and entered into the WHO Classification of Tumours of 
Haematopoietic and Lymphoid Tissues.
 Hussein et al. give a comprehensive overview on the 
pathogenesis of PTLD in general as well as focusing on a 
particular patient group, namely pediatric patients. The 
role of specific site involvement is underlined by the ex-
amples of the central nervous system and the skin, dis-
cussed in the papers by C. Kempf et al. and W. Kempf et 
al., respectively. W. Kempf et al. illustrate nicely how pri-
mary cutaneous PTLD differs in many aspects from its 
nodal and extranodal counterparts.
 Second, lesions related to immunosuppressive drugs 
represent a paradigm of a close, reciprocal interconnec-
tion of the functionality of the immune system, viral rep-
lication and tumorigenesis. Lessons were learned. For 
 example, on the one hand, that the reduction of immu-
nosuppression leads to a regression of Epstein-Barr virus-
induced lymphoproliferations and therefore chemother-
apy upfront is maybe not necessary. On the other hand, 
accumulations of viral-induced cancers such as human 
papillomavirus-positive squamous cell carcinomas of the 
skin or Merkel cell polyomavirus in Merkel cell carcino-
ma and  human herpesvirus 8 -induced Kaposi sarcoma 
were more frequently observed in these patients, as shown 
by W. Kempf et al.
 Third, we became aware of rare and thus far unknown 
viral-induced malignancies. Hussein et al. provide an
 Intact immunity is dependent on the interaction of
a variety of immune cells and a multitude of secreted 
 molecules. Hence, minor malfunctions in this complex 
system may substantially impact on the efficiency of the 
immune system, ultimately leading to the same result, 
namely increased susceptibility to infection and tumori-
genesis. This special issue of  Pathobiology on immuno-
suppression-associated pathology focuses on pathologies 
evolving from secondary immunodeficiency states in-
duced by immunomodulatory drug therapy in the con-
text of autoimmune diseases and in the prevention of 
transplant rejection.
 Research on pathways and components that are more 
selectively interfering with the immune system has led to 
the emergence of a wealth of new immunomodulatory 
drugs. Their increased availability goes along with a wid-
ened clinical indication including various autoimmune 
diseases. In his overview, Kovarik delineates the most im-
portant principles of therapeutic immune modulations 
and their clinical indications as well as potential side ef-
fects.
 In the past, histological investigations of tissues from 
patients treated with first-generation immunosuppres-
sive drugs taught pathologists a different approach to this 
collective, as outlined beneath.
 First, a spectrum of new categories of lymphoprolif-
erative disorders, e.g. posttransplant lymphoproliferative 
disorder (PTLD) or other iatrogenic immunodeficiency-
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example of the poorly known Epstein-Barr virus-associ-
ated smooth muscle tumors in immunocompromised 
children.
 Moreover, recently developed drugs like mycopheno-
late can mimic graft-versus-host disease or infectious 
colitis including cytomegalovirus infection, a distinction 
which is of utmost clinical importance but creates a chal-
lenging task, as Weber et al. describe in their article.
 In summary, this special issue on immunosuppres-
sion-associated pathology aims at giving an overview of 
little-known aspects in histopathological diagnosis in the 
context of secondary immunosuppression. Moreover, we 
present an up-to-date overview on currently available im-
munosuppressive treatment concepts and their potential 
diagnostic pitfalls. In particular, we hope to heighten the 
awareness of pathologists and clinicians to the fact that 
the management of immunosuppressed patients calls for 
an approach different from that of immunocompetent 
patients.
 M. Tinguely 
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